Internal Reference Number: FOI_6396
Date Request Received: 10/12/2021 00:00:00
Date Request Replied To: 04/01/2022 00:00:00
This response was sent via: By Email
Request Summary: Treatment of Ovarian cancer
Request Category: Companies
| Question Number 1: How many patients have been treated for advanced (FIGO Stages III and IV) high-grade ovarian (epithelial ovarian, fallopian tube or primary peritoneal) cancer over the last 3 months? If none, do you refer ovarian cancer patients to another trust, if so which one? | |
| Answer To Question 1: 4 patients | |
| Question Number 2: How many ovarian cancer patients (any stage) have been treated in the last 3 months with: • Paclitaxel in combination with a platinum-based compound • Platinum-based therapy alone (cisplatin or carboplatin) • Bevacizumab in combination with paclitaxel and carboplatin • Olaparib • Olaparib + Bevacizumab • Niraparib • Rucaparib | |
| Answer To Question 2: • Paclitaxel with platinum 9 • Platinum alone 7 • Bevacizumab with paclitaxel/carboplatin 5 • Olaparib 0 • Olaparib+ bev 0 • Niraparib 5 • Rucaparib 1 | |
| Question Number 3: Of the ovarian cancer patients (any stage) treated over the last 3 months, how many patients: • Received HRD (homologous recombination deficiency) testing • Received BRCA testing • Tested HRD positive • Tested BRCA positive (BRCAm) | |
| Answer To Question 3: • Received HRD testing: 8 • Received BRCA testing: 19 • Tested HRD positive: 0 • Tested BRCA positive: 1 | |
| Question Number 4: If data for HRD testing is available, please provide how many HRD positive patients were treated in the last 3 months with: • Olaparib • Olaparib + Bevacizumab • Niraparib • Other treatments | |
| Answer To Question 4: 0 | |
| Question Number 5: If data for HRD and BRCA testing is available, please provide how many HRD positive-BRCA positive patients were treated in the last 3 months with: • Olaparib • Olaparib + Bevacizumab • Niraparib • Other treatments | |
| Answer To Question 5: • 1 patient – ‘other treatment’ treated with carboplatin/paclitaxel | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
